Literature DB >> 26534748

Hereditary angioedema: special consideration in children, women of childbearing age, and the elderly.

James L Kuhlen1, Aleena Banerji.   

Abstract

This review on hereditary angioedema (HAE) focused on special topics regarding HAE in children, women of childbearing age, and the elderly. HAE is a rare autosomal dominant bradykinin-mediated disorder characterized by recurrent attacks of subcutaneous or submucosal swelling that usually affects the face, upper airway, extremities, gastrointestinal tract, or genitalia. These recurrent attacks cause significant morbidity and can be life threatening, especially when the swelling affects the airway. Our objective was to summarize the published data available on the disease epidemiology, pathophysiology, clinical presentation, on demand and prophylactic therapy, and focus on management considerations for these special patient populations. Unique aspects of HAE in women with regard to contraception, hormone replacement therapy, pregnancy, lactation, and menopause were also reviewed.

Entities:  

Mesh:

Year:  2015        PMID: 26534748     DOI: 10.2500/aap.2015.36.3911

Source DB:  PubMed          Journal:  Allergy Asthma Proc        ISSN: 1088-5412            Impact factor:   2.587


  6 in total

1.  Asthma, allergy, and psychiatric disease.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2015 Nov-Dec       Impact factor: 2.587

2.  Insights, strategies, asthma and allergy risk factors, and the allergist/immunologist: Challenges to be met and promises to keep!

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2016 Jan-Feb       Impact factor: 2.587

3.  Atopy, asthma, and the elderly: A paradigm for personalized therapy.

Authors:  Joseph A Bellanti; Russell A Settipane
Journal:  Allergy Asthma Proc       Date:  2017-05-01       Impact factor: 2.587

Review 4.  [Age-specific aspects in the treatment of angioedema patients].

Authors:  P Staubach
Journal:  Hautarzt       Date:  2019-02       Impact factor: 0.751

Review 5.  Review of Select Practice Parameters, Evidence-Based Treatment Algorithms, and International Guidelines for Hereditary Angioedema.

Authors:  Jaison Jose; Jamie Zacharias; Timothy Craig
Journal:  Clin Rev Allergy Immunol       Date:  2016-10       Impact factor: 8.667

6.  Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert® (C1-INH) Registry.

Authors:  Anette Bygum; Inmaculada Martinez-Saguer; Murat Bas; Jeffrey Rosch; Jonathan Edelman; Mikhail Rojavin; Debora Williams-Herman
Journal:  Drugs Aging       Date:  2016-11       Impact factor: 3.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.